4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001104659-22-027432
Director bought 420,380 shares at an average $13.23 ($5,559,664)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. Director | 2022-02-23 | Purchase | +214,922 | $13.41 | $2,883,114 | 10,867,959 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2022-02-24 | Purchase | +186,467 | $13.03 | $2,429,851 | 11,054,426 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2022-02-25 | Purchase | +18,991 | $12.99 | $246,699 | 11,073,417 | I |
| Open-market purchases · 420,380 sh · avg $13.23 · $5,559,664 | |||||||
Loading xslF345X03/tm227791-1_4.xml…